Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Mycopathologia|September 5, 2012
Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hostsElitza S Theel, Deborah J Jespersen, Seher Iqbal, et al.
Journal of Clinical Microbiology|July 14, 2021
Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory StatusDavid R Peaper, Daniel D Rhoads, Kaede V Sullivan, et al.
Plos One|August 4, 2022
Predictors of chronic COVID-19 symptoms in a community-based cohort of adultsJonathan I Silverberg, Israel Zyskind, Hiam Naiditch, et al.
Open Forum Infectious Diseases|December 10, 2021
A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 StudyParham Sendi, Rossella Baldan, Marc Thierstein, et al.
JAMA Network Open|March 10, 2021
SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United StatesIsrael Zyskind, Avi Z Rosenberg, Jason Zimmerman, et al.
Scientific Reports|November 17, 2022
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentrationSebastian Fiedler, Sean R A Devenish, Alexey S Morgunov, et al.
Immunity, Inflammation and Disease|June 27, 2022
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohortParham Sendi, Marc Thierstein, Nadja Widmer, et al.
Journal of Medical Virology|June 30, 2023
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohortParham Sendi, Nadja Widmer, Mattia Branca, et al.
Journal of Lower Genital Tract Disease|May 25, 2026
Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical SpecimensJissy Cyriac, Elitza S Theel, Margaret E Long, et al.
Microbiology Spectrum|July 21, 2022
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA ThresholdsNicholas E Larkey, Radwa Ewaisha, Michael A Lasho, et al.
Pageof 13